Physician profile
Gregory Brusko
NPI 1235766775
$7,388.86
in general payments reported to CMS, 2019-2025
7 companies · $425 in 2025
The $425 reported for 2025 was more than what 76% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $166 · 2022: $1,606 · 2023: $1,872 · 2024: $3,321 · 2025: $425.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,648 · Travel and Lodging: $1,969.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,647.96 |
| Travel and Lodging | $1,969.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,872.92 | 2023-2024 | Aero-Ll, N/A, Serrato |
| Medtronic, INC. | $2,381.64 | 2021-2025 | Unid_pass, Mazor X System, Stealthstation S8 Platform |
| Globus Medical, INC. | $681.08 | 2024 | Xlif, Reline, Versatie |
| Integra Lifesciences Corporation | $178.53 | 2021-2022 | |
| Medical Device Business Services, INC. | $134.77 | 2024-2025 | Symphony, Teligen |
| Vb Spine LLC | $114.91 | 2025 | Aviator, Capri Corpectomy Cage System, Napa Access System |
| Depuy Synthes Sales INC. | $25.01 | 2025 | Synthecel, Matrixneuro |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Brusko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.